Blog / Archives
Momentum Easing But Biotech Stocks Holding Near Top .. Update -1 PBYI
Life Science Stocks At Ease After 5% Gain in November Stocks Come Back In Late Day Trading 12/4 After 3 down days with the S&P, biotechnology stocks are holding near sector highs with the IBB at...
Biotechnology Sector Closes Month At New Highs Up 5%: BIIB, IBB,VRTX
Biotechnology Stocks Hits New Highs After A Choppy 60 Days Biotechnology stocks eked out small gains today taking the liquid $4.4B market cap ETF (IBB) to new highs at $225 up 5.58% for the week...
Biotech Rally Update at New Highs: ETFs (IBB,PBE) Beat Five Star Fidelity Fund (FBIOX)
Up until recently the Fidelity Select Biotechnology Fund (FBIOX) has outperformed all ETFs but now the IBB and PBE are leaders over the last 3 months. There have been two recent mini-corrections but...
Another Biotech Melt-Up Underway-IBB Up 2.33%
Large Cap Biotechs Rocketing Up:BIIB, GILD Despite a flattish Dow and S&P, many life science stocks are surging ahead. There are many movers in the Rayno Biopharmaceutical Portfolio : Biogen...
NanoString Technologies (NSTG): An Emerging Growth Play In Molecular Diagnostics
NanoString Technologies (NSTG $12) is an early stage, life science research Company with a proprietary platform product, the nCounter (R) Analysis System. The nCounter utilizes a proprietary bar...
Rayno Diagnostics And Tools Update: CSII, HOLX, ILMN, NSTG-Strong Rally Today
Another Strong Day in Life Science Stocks Carl Icahn, activist investor takes a 13% stake in Hologic. Hologic (HOLX $22.82) was added to our portfolio on 4/9/13 but has been a laggard due to...
Scenes From a Speculative Market: ONVO
Bull Market Intact But Momentum Stocks Taking Hits Most of you know the game. Buy stocks with headline news, new business models, increasing RSI and charts that scream momentum. Examples...
Rayno Biopharmaceuticals Portfolio: REGN, VRTX Update -1
Vertex (VRTX $67) Contrarian Trade Working Vertex is one of the worse performing large cap biotechs over 6 mos. is getting boosted on a $152M royalty deal. "Risk-On "Mode in Biotech Stocks Biotech...
Life Science Stocks Boosted By Genomic Technologies and New Diagnostic Products
Rayno Diagnostics and Tools Focus Stocks: 2013 Performance YTD A diversified life science portfolio must include clinical diagnostics and tools stocks because the synergies between therapy and...
“Long Only” Funds? Shorting Stocks Is So 2008
Isn't A "Long Only" Hedge Fund A Mutual Fund? The news from Monday's November 11 Wall Street Journal on p C1 is that hedge funds who are shorting stocks are underperforming the market and most...